
Another important characteristic of THJAMA' Filler is the product fluidity. Different from several companies, which the product injection is hard due to the high viscosity, the injection of THJAMA' Filler is smooth and comfortable. The personalized syringe with unique piston shape, gives a great grip, security and easy handling for the operator and, in consequence, a comfortable procedure for the patient. It is also very important to mention the great plastic feature of THJAMA' Filler when it is on-site as it can be mouldable by the doctors with the standard post procedure massage as it takes the desired shape and remains at the site.
Monophasic: no particle sizedata avaialble
Ha molecular weight:
1-1.5 M Da
Osmolatility: 300 mOsm/Kg
Needles:
Soft>30G, Medium/Strong >27G, Extra Strong >25G
The process developed by THJAMA' LAB makes possible to obtain products characterised by dynamic viscosity that can be modulated according to the degree of crosslinking, concentration and molecular weight of the hyaluronic acid.
The M.M.A (macroMolecularAlignment) technology exploits the combination of heat and a direct mechanical extrusion step during the production phase, which is able to align the cross-linked hyaluronic acid molecules. This facilitates the extrusion of the gel from the syringe without compromising the dynamic viscosity of the product.
The low cohesivity of the Soft product guarantees a high distribution of the product especially in the upper layers of the dermis, favouring its ability to perform a hydrating action on the tissues. On the contrary, Strong and Extrastrong fillers exhibit a high cohesivity, ideal to perform a filling and volumizing action.
*Zerbinati N. Et al, Polymers 2021;13:948
**Sundaram H et al. Plastic And Reconstr. Surgery. 2015;
136(4):678
The elastic modulus (G') greater than 150 Pas of products such as Strong and Extrastrong guarantees a high mechanical response to transverse (parallel tissue movements) and perpendicular stresses (skin projection)
*Determinata a 0.1 Hz
**Falcone et al. J. Of Biomedical Mat. Res, 2008; 264:71
The percentage of elasticity of OPERA fillers guarantees the products' ability to match the dynamics of facial expressions, thanks to the plastic and volumetric role played by facial fillers.
The M.F.HA (Micro-fragmentation HA) technology reduces the size of the cross-linked gel particles to the size of afew millimetres, favouring better hydration, a higher degree of swelling and a favourable ratio between elastic and viscous modulus over a wide stress range.
Fillers consist of only Pharma grade biotechnological hyaluronicacid. The absence of contaminants and by-products linked to the process guarantees the high safety and security of the product during use and in the biodegradation phase,induced exclusively by the presence of hyaluronidases that fragment the biopolymer, ensuring the metabolic pathway*
*ZhongS.P.etal. Biomaterials. 1994; 15(5):359
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 96.82 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.0 |
BDDE | 2425-79-8 | Cross-linker | 0.18 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.30 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.63 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.07 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 96.66 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.0 |
BDDE | 2425-79-8 | Cross-linker | 0.19 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.31 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.67 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.07 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 96.19 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.40 |
BDDE | 2425-79-8 | Cross-linker | 0.21 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.36 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.76 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.08 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 95.87 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.60 |
BDDE | 2425-79-8 | Cross-linker | 0.23 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.39 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.82 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.09 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |
Our revolutionary macromolecular advanced hyaluronic acid body filler 100% Made in Italy. It remodels the body in a totally safe way without surgery. It allows to harmonize the large volumes of the body such as glutes, calves, forearms and areas where a natural redefinition of the body silhouette is necessary.
Last generation body filler production
The doctor can count on a
safe, quality and easy to use product.
During the production and packaging process we carry
out numerous verification tests on all the fillers produced,
guaranteeing the
total purity and efficency of the injectable
product and the sterility of its packaging.
Thanks to the special formulation, it ensures optimal hydration and reinvigoration of muscle and tissues for a perfect reshaping.
Already after the first application your silhouette will appear more compact and outlined. Moreover, unlike most other invasive treatment, this body filler needs less time before resuming normal activities
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 96.82 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.0 |
BDDE | 2425-79-8 | Cross-linker | 0.18 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.30 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.30 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.07 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |
All our fillers are class III medical devices. In order to achieve the best possible clinical results, all formulations are developed with a focus on individual application purposes by using a combination of hyaluronic acids of different molecular weights in order to obtain different visco-elastic properties. These products have been developed to reshape tissues, noticeably reducing skin laxity, and to restore the skin's natural appearance by replenishing it with moisture, tone and radiance.
The biorevitalizing fillers act on skin aging, especially of the face and neck, characterized by cellular depletion with relative reduction of tone and formation of wrinkles. They allow a rapid rejuvenation of the dermis and an immediate skin toning. This filler is ideal for the correction of minor facial skin depressions. It prevents and acts on photo aging and chrono aging damages.
Other characteristics
low viscosity in a
syringe of 2 ml
Extra characteristic
excellent for décolleté and neck rejuvenation as well
Ahydrated, radiant-looking
and even-textured
complexion, that lasts longer
with increased effectiveness
and a double dose.
INGREDIENTS | CAS NUMBER | FUNCTION | % (g/100ml) |
---|---|---|---|
Water for injections | 7732-18-5 | Solvent | 96.91 |
Sodium Hyaluronate | 9067-32-7 | Active ingredient: filling and moisturizing agent | 2.0 |
BDDE | 2425-79-8 | Cross-linker | 0.09 |
Sodium Hydroxide | 1310-73-2 | Buffering agent | 0.30 |
Hydrochloric acid (37%) | 7647-01-0 | Buffering agent | 0.63 |
Phosphoric acid (85%) | 7664-38-2 | Buffering agent | 0.07 |
PARAMETERS | STANDARD VALUES | METHOD |
---|---|---|
Physical Aspect | Gel | Visual |
Colour | Colorless | Visual |
PH | 6,5 ± 1 | CH01 (pH meter) |
BDDE residue | < 2 ppm | GC - MS |
Hyaluronate title | ≥2,0% | UV-VISIBLE |
Sterility test | Sterile | ISO 11737-2 |
Bacterial Endotoxin Detection | ≤ 0,50 EU/ml | EP 2.6.14, USP 85 |
Volume Control | 1g± 5% | CH03 (analytical balance) |